Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia plans 2006 roll out of national colorectal screening:

This article was originally published in Clinica

Executive Summary

Australia will invest Aus$43.4m (US$36.9m) in extending nationally its national bowel cancer screening programme from May 2006. The announcement has come after the final evaluation of the Bowel Cancer Screening Pilot Programme, which has shown that screening of the target population aged 55-74, using faecal occult blood test (FOBT) with colonoscopy as the follow-up procedure, is "feasible, acceptable and cost-effective". Australia has one of the highest rates of bowel cancer in the world, affecting around 1 in 17 men and 1 in 26 women by the age of 75. Early detection of the disease is critical to improving outcomes and survival.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT058019

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel